The protective efficacy of Bharat Biotech's Covaxin following two and three-dose immuniszations against the Delta variant and the efficacy ...

On Wednesday, Glenmark and its partner Canada-based SaNOtize Research & Development Corp announced the launch of NONS under the brand name ...

Some argue that Omicron is 'mild', but this wave is sweeping through a population.

The firm has developed the API (active pharmaceutical ingredient) in house at its R&D centre here. Optimus Pharma has revealed highly promi...

The company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...

The cell is then tricked into reproducing the virus's genetic material and packaging it into virions, particles which burst from the cell a...

Ivermectin resulted in a reduction of virus replication in laboratory studies, the university said, adding that a small pilot showed giving...

In January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, incl...

Nine other clinical trials involving Siddha medicine either as stand-alone or adjunct with allopathic medicine that were taken up throughou...

The researchers, including those from the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad, advise testing asymptomatic pr...

"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...

If the drug proves to be efficacious for Covid treatment, Glenmark will cash in on first mover advantage.

The firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.

Over 50 clinical trials for a Covid-19 vaccine have started in India as researchers globally look for ways to stop the ravaging pandemic.

xperts are now gearing up for the next step, which is to hold clinical trials and toxicity studies before seeking permission from the Minis...

St George's, University of London is collaborating with Bionor Pharma to study HIV-associated immune activation that drives disease progres...